LabGenomics CI (Photo by LabGenomics)
[Asia Economy Reporter Chunhee Lee] LabGenomics, a molecular diagnostics specialist company, announced on the 24th that it recently signed a supply contract for 'Direct to Consumer (DTC) genetic testing' with BankSalad, a MyData specialist company.
BankSalad has been providing DTC genetic testing services to application (app) users since October last year. LabGenomics recently signed a supply contract for DTC genetic testing with BankSalad and has been exclusively supplying the service since October. BankSalad's DTC genetic testing service has gained great popularity, attracting 210,000 users in one year, and BankSalad and LabGenomics plan to expand the annual number of service provisions to over 600,000 next year.
LabGenomics emphasized that this contract was made because it was recognized as a testing institution capable of stably performing the highest number of tests per day on average. Starting with this contract, they plan to lead the popularization of genetic testing through continuous collaboration with BankSalad and to launch other types of testing services.
LabGenomics is also expected to accelerate the acquisition of the US contract analysis institution CLIA Lab, which is currently underway. Through this, they plan to create various synergies with the domestic genetic testing business.
A LabGenomics official said, "This contract will be a cornerstone for advancing as a digital healthcare company," adding, "We plan to actively engage in a personalized digital healthcare platform business utilizing genetic data across health, life, and beauty."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
